Die weltweit größten Unternehmen, Investoren und Organisationen vertrauen auf unsere Erfahrung, um die richtigen Entscheidungen in einer sich rasant verändernden Welt zu treffen. Wir verbinden außergewöhnliche Leistung mit entscheidendem Wissensvorsprung zur Lösung komplexester Probleme, wo und wann immer sie sich unseren Mandanten stellen.
Lesen Sie hier, wie unsere Anwältinnen und Anwälte aktuelle wirtschaftsrechtliche Themen einschätzen.
Wir bringen frische Perspektiven, umfassende Erfahrung und die neuesten Erkenntnisse in jede Aufgabe ein.
Jede Unternehmenskultur ist einzigartig – wir laden Sie herzlich ein, unsere kennenzulernen.
Werden Sie Teil unseres globalen Teams
How the US is responding to COVID-19
Below you will find a collection of our latest thoughts and insights on the impacts of the COVID-19 pandemic in the United States.
US: can the failing firm defence save a deal?
Corruption risk and enforcement in the time of COVID
US, Argentina and Brazil: contractual performance uncertainty
COVID-19: three avenues for US distressed M&A
US: are companies required to use contact tracing technology
Americas: adequate assurance and breach of contract
US: NYC state courts to allow the filing of new complaints
US: New York continues suspension of its statute of limitations
US: COVID-19's impact on the financial services sector
US: travelers’ right to refunds and airlines’ right to survival
US: legal implications of contact tracing apps
US: Nasdaq gives temporary shareholder approval relief for some capital raising
US: avoiding disclosure liabilities under securities laws
US: NY courts still not accepting nonessential lawsuits
US: recently filed MAE/MAC cases (part 2)
US: contact tracing apps
US: Nasdaq temporarily relaxes certain continued listing requirements
US: oral arguments and court hearings during COVID-19
US: recently filed MAE/MAC cases
US: seven governance and risk management guideposts
US: proxy advisory firms provide perspective on COVID-19 impact
US: NYSE temporarily relaxes some equity issuance requirements
US: Paycheck Protection Program - making applications
US: poison pill adoptions and what boards need to do now
US: M&A and MAE - the why and how of interim operating covenants
US: Delaware’s warning on distressed acquisitions
US Federal Reserve: further crisis funding
US: COVID-19 litigation just beginning
US: SEC urges 'good corporate hygiene'
US aviation sector: CARES Act - key considerations
US: court filings trends during the pandemic
US: financing under the CARES Act
US: comparison of government financing programmes (PDF, 155K)
US commercial contracts: risks for global companies
US: avoiding mis-steps while in financial distress
US: CARES Act and private equity
US: recording videoconferences - the legal risks
US: close-out litigation - risks and tips
US: private investments in public equity
US: SEC guidance for public companies
US financial institutions: compliance risks
US airline sector: financial relief
US: debt buybacks
US: government monetary and fiscal actions
US: adequate assurance
US: CARES Act - SME lending provisions
US: CARES Act - business tax provisions
US: CARES Act - Paycheck Protection Program
US: CARES Act - financing provisions
US: issuing equity to the government for aid
Compliance risk: lessons from prior crises
US medical privacy and the coronavirus
US: New York suspends its statute of limitations
US: coronavirus, force majeure and foreseeability
US: fiduciary duties in volatile times
11 concerns for parties to US financings
US: contractual assurances and litigation risk
Tech sector M&A: adding R&W insurance to the toolkit
How COVID-19 is affecting contractual and deal terms
US: how to hold a virtual shareholder meeting
US: performance-based awards for employees of public companies
US ban on travel from Europe: the implications
The impact on start-up financing
